SLC3A2 and carcinoma: Thus, SLC3A2/4F2hc (also known as CD98), the obligate interaction partner of LAT1, although not a transporter itself, is a potential target as well due to its elevated expression in various carcinomas and neoplasms, and as a consequence of intestinal inflammation [151,152].